CLINICAL RESEARCH SITES FOR THE NIAAA MEDICATIONS DEVELOPMENT CLINICAL INVESTIGATIONS NETWORK FOR THE TREATMENT OF ALCOHOL USE DISORDER Solicitation ID/Procurement Identifier: RFP-NIH-NICHD-NIAAA-2020- Ultimate Completion Date: Tue Mar 14 17:00:00 GMT 2028
The purpose of this acquisition is for The National Institute on Alcohol Abuse and Alcoholism (NIAAA) to establish a network of multiple clinical research sites to conduct Phase II (and Phase I leading to Phase II) clinical research studies involving human subjects for the NIAAA Medications Development Clinical Investigations Network for medications development for the treatment of Alcohol Use Disorder.
This Research and Development contract was awarded on behalf of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and is one of multiple Indefinite Delivery, Indefinite Quantity contracts awarded for clinical research sites to participate in the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder.
This Research and Development contract was awarded on behalf of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and is one of multiple Indefinite Delivery, Indefinite Quantity contracts awarded for clinical research sites to participate in the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder.
The creation of the NIAAA's Medications Development program was recommended by the NIAAA Extramural Advisory Board on Medications Development, a subcommittee of Council, February 7-8, 2005 and subsequently approved by the full NIAAA National Advisory Council, June 2005. The Council recognized the urgent need for a rapid and efficient mechanism to conduct clinical trials of promising compounds to treat alcohol problems.
It supports medication testing on measures of alcohol drinking, negative affect, and pain using in the chronic intermittent ethanol (CIE) vapor exposure model in rats and expires September 26, 2023.To address the present and anticipated future needs of NIAAA’s Medication Development Program, the LSUSC contract is being recompeted to continue supporting work within the same scope, i.e., medication testing in rats using the CIE model and alcohol drinking
This is NOT a NIH grant opportunity.The NIAAA seeks a contractor to address the present and anticipated future needs of NIAAA's Medications Development Program for the blind efficacy testing of reference compounds, compounds of interest and proprietary compounds supplied to NIAAA from industry suppliers on voluntary alcohol drinking by alcohol preferring P and HAD1 rats.
